Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs. [electronic resource]
Producer: 20120508Description: 104-9 p. digitalISSN:- 1815-7920
- Antitubercular Agents -- therapeutic use
- Bacterial Proteins -- genetics
- Capreomycin -- therapeutic use
- DNA Gyrase -- genetics
- DNA Mutational Analysis
- Drug Resistance, Multiple, Bacterial -- genetics
- Ethambutol -- therapeutic use
- Genotype
- Humans
- Kanamycin -- therapeutic use
- Kanamycin Resistance -- genetics
- Microbial Sensitivity Tests -- methods
- Mutation
- Mycobacterium tuberculosis -- drug effects
- Ofloxacin -- therapeutic use
- Pentosyltransferases -- genetics
- Phenotype
- Polymerase Chain Reaction
- Predictive Value of Tests
- RNA, Bacterial -- genetics
- RNA, Ribosomal, 16S -- genetics
- Sensitivity and Specificity
- Tuberculosis, Multidrug-Resistant -- diagnosis
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.